Reading causes myopia

Article

Reading may be a risk factor for childhood myopia, according to a study published in the August 2008 issue of the British Journal of Ophthalmology.

Reading may be a risk factor for childhood myopia, according to a study published in the August 2008 issue of the British Journal of Ophthalmology.

Surgeon Cathy Williams of the Centre for Child and Adolescent Health, Bristol Eye Hospital, UK and colleagues aggregated and evaluated data gathered from a birth cohort study and results of tests including school Standardised Assessment Tests (SATS), the Wescher Objective Reading Dimension (WORD) test, verbal and non-verbal IQ tests with likelihood of being myopic (possessing spherical autorefraction of -1.50 D) and parental report of enthusiasm for reading of children aged 7 and 10 years at baseline (n=6871).

At the age of seven, 1.5% of the children were classified "likely to be myopic" by age 10. After adjusting for myopic parents and ethnicity, risk factors for inclusion in this group included good results from reading, maths, WORD and verbal IQ tests, but the single strongest factor predicting likelihood of myopia was whether the child was reported to enjoy reading: children who did so were four times as likely to develop myopia than children who did not enjoy reading.

The researchers concluded that it is likely that reading, or factors associated with reading, play a role in the development of myopia.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.